Myocardial infarction with ST-elevation treated by primary percutaneous intervention facilitated by early Reopro [abciximab] administration in Alsace

Trial Profile

Myocardial infarction with ST-elevation treated by primary percutaneous intervention facilitated by early Reopro [abciximab] administration in Alsace

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Aug 2010

At a glance

  • Drugs Abciximab (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms MISTRAL
  • Most Recent Events

    • 28 Aug 2010 Status changed from active, no longer recruiting to completed, based on an abstract presented at the Annual Congress of the European Society of Cardiology.
    • 28 Aug 2010 Results presented in an abstract at the Annual Congress of the European Society of Cardiology.
    • 28 Aug 2010 Primary endpoint 'Complete ST segment resolution' has not been met, according to an abstract presented at the Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top